Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

49.59
Delayed Data
As of 4:02pm ET
 +0.26 / +0.53%
Today’s Change
36.81
Today|||52-Week Range
50.24
+22.63%
Year-to-Date
Good Companies From Warren Buffett's Portfolio
Jun 23 / GuruFocus News - Paid Partner Content
Seattle Genetics (SGEN) Submits BLA to FDA for Cancer Drug
Jun 21 / Zacks.com - Paid Partner Content
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
Jun 23 / Zacks.com - Paid Partner Content
Horizon Pharma Gets Health Canada Approval for Procysbi
Jun 20 / Zacks.com - Paid Partner Content
Why Gilead Sciences Is Nearing Yet Another Mind-Bending Breakout
Jun 23 / TheStreet.com - Paid Partner Content
4 Buy-Ranked Large Cap Pharma Stocks to Add to Your Portfolio
Jun 20 / Zacks.com - Paid Partner Content
Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
Jun 22 / Zacks.com - Paid Partner Content
Sanofi: Should Value Investors Consider SNY Stock?
Jun 19 / Zacks.com - Paid Partner Content
Why You Should Add Novo Nordisk Stock to Your Portfolio
Jun 22 / Zacks.com - Paid Partner Content
Pfizer (PFE) Buys Exclusive EU Rights to Anti-Fungal Drug
Jun 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close49.33
Today’s open49.80
Day’s range49.56 - 49.87
Volume1,089,619
Average volume (3 months)1,785,353
Market cap$127.0B
Dividend yield3.31%
Data as of 4:02pm ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)+11.60%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.35%
Revenue growth (last year)-2.08%
P/E ratio29.2
Price/Sales2.81
Price/Book2.04

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.10+0.14%
GSKGlaxoSmithKline-0.22-0.50%
CELGCelgene-0.46-0.34%
BMYBristol-Myers Squibb+0.28+0.49%
Data as of 4:14pm ET, 06/26/2017

Financials

Next reporting dateJuly 31, 2017
EPS forecast (this quarter)$0.73
Annual revenue (last year)$37.3B
Annual profit (last year)$5.2B
Net profit margin12.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts